Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P900060/S070

CARBOMEDICS PROSTHETIC HEART VALVE, CARBOMEDICS SUPRA-ANNULAR PROSTHETIC HEART VALVE, OPTIFORM PROSTHETIC MITRAL HEART

Corcym S.r.l. · Decision date Jul 28, 2026

FDA DECISIONP900060/S070

What did the FDA decide?

FDA records P900060/S070 as a supplement to PMA P900060, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 28, 2026.

FDA approval order statement

implementing equipment to automatically conduct dimensional and visual inspections during the manufacturing process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P900060/S070
Regulatory pathway
PMA supplement
Applicant
Corcym S.r.l.
Product code
LWQ
Decision code
OK30
Decision date
Jul 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: HEART-VALVE, MECHANICAL.

Applicant
Corcym S.r.l.
Product code
LWQ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P900060/S069 · Related supplement

    Carbomedics Prosthetic Heart Valve; Carbomedics Supra-annular Prosthetic Heart Valve; Carbo-Seal Ascending Aortic Pros

  2. P900060/S070 received

    Application receipt date recorded by FDA.

  3. P900060/S070 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P900060. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P900060

Product / regulatory recordCompanyPathwayDecision dateSource
Corcym S.r.l.PMA supplementDec 17, 2025FDA

Explore the linked device profile

Other records with product code LWQ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Corcym S.r.l.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Via Crescentino Sn, Saluggia, 13040

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records